Correlation between serum Visfatin and cognitive impairment in maintenance hemodialysis patients

ObjectiveTo study the correlation between serum Visfatin and cognitive impairment (CI) in maintenance hemodialysis (MHD) patients.MethodsIt was a cross-sectional study. From July 1, 2023 to January 31, 2024, baseline characteristics of MHD patients treated in the Beijing Luhe Hospital,Capital Medica...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Xiao-qi, Liu Cong-hui, Ma Ye-ping, Cao Qian-ying, Shao Feng, Li Zhong-xin
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2025-04-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/article/doi/10.3969/j.issn.1671-2390.2025.04.007
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849715463637958656
author Wang Xiao-qi
Liu Cong-hui
Ma Ye-ping
Cao Qian-ying
Shao Feng
Li Zhong-xin
author_facet Wang Xiao-qi
Liu Cong-hui
Ma Ye-ping
Cao Qian-ying
Shao Feng
Li Zhong-xin
author_sort Wang Xiao-qi
collection DOAJ
description ObjectiveTo study the correlation between serum Visfatin and cognitive impairment (CI) in maintenance hemodialysis (MHD) patients.MethodsIt was a cross-sectional study. From July 1, 2023 to January 31, 2024, baseline characteristics of MHD patients treated in the Beijing Luhe Hospital,Capital Medical University were collected. Serum level of Visfatin was evaluated using fasting blood samples. Cognitive function was assessed using the Montreal cognitive assessment scale (MoCA). According to the results of MoCA, the patients were divided into cognitive impairment (CI) group and non-CI group. Clinical characteristics were compared between groups. Multivariate logistic regression was employed for analyzing the independent influencing factors for CI. Receiver operating characteristic (ROC) curve was used to analyze the predictive value of influencing factors for CI in MHD patients.ResultsTotally 146 MHD patients were enrolled in this study and divided into non-CI group (n=46) and CI group (n=100). Compared to the non-CI group, patients in the CI group had significantly older age [66.00(57.25,71.00)years vs 45.50(40.00,56.25)years], higher proportion of diabetes (56% vs 32.6%), Visfatin level [13.35(7.68,24.68)μg/L vs 7.46(4.46,14.07)μg/L], blood sugar [(11.13 ± 5.34)mmol/L vs (9.17 ± 4.46)mmol/L], body mass index [24.29(21.24,26.21)kg/m2 vs 21.36(19.94,24.85)kg/m2], and C-reactive protein[(16.60 ± 23.37)mg/L vs (8.24 ± 10.41)mg/L] (P<0.05). Patients in the CI group had significantly lower education years[9.00(6.00,9.00)years vs 12.00(9.00,12.75)years], albumin (Alb)[40.35(37.70,42.18)g/L vs 42.15(40.28,44.58)g/L], serum creatinine [731.00(632.75,876.00)μmol/L vs 951.00(828.75,1102.50)μmol/L], blood sodium [136.5(135.0,138.0)mmol/L vs 137.5(136.0,139.0)mmol/L], and blood phosphorus [(1.68 ± 0.52)mmol/L vs(1.90 ± 0.57)mmol/L] than non-CI group (P<0.05). Multivariate logistic regression analysis showed that increasing age, high Visfatin level, low education level and Alb level were independent risk factors for CI in MHD patients. ROC curve showed that the area under the curve (AUC) of Visfatin for predicting CI in MHD patients was 0.714 (P<0.01), with the sensitivity of 71.7% and the specificity of 75.0%, which had high predictive value. When Visfatin, Alb, age and education level were combined, the AUC for predicting CI was 0.87, the sensitivity was 78.0% and the specificity was 84.8% (P < 0.01) which performed better in the predictive value than any single indicator.ConclusionFor MHD patients, high Visfatin level is an independent risk factor for CI, which may become a biological indicator for predicting CI.
format Article
id doaj-art-e14630647d1d4047900ca694cc1b9b92
institution DOAJ
issn 1671-2390
language zho
publishDate 2025-04-01
publisher Editorial Department of Journal of Clinical Nephrology
record_format Article
series Linchuang shenzangbing zazhi
spelling doaj-art-e14630647d1d4047900ca694cc1b9b922025-08-20T03:13:22ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902025-04-0125431231810.3969/j.issn.1671-2390.2025.04.0071671-2390(2025)04-0312-07Correlation between serum Visfatin and cognitive impairment in maintenance hemodialysis patientsWang Xiao-qi0Liu Cong-hui1Ma Ye-ping2Cao Qian-ying3Shao Feng4Li Zhong-xin5Department of Nephrology,Beijing Luhe Hospital,Capital Medical University,Beijing 101149,ChinaDepartment of Nephrology,Beijing Luhe Hospital,Capital Medical University,Beijing 101149,ChinaDepartment of Nephrology,Beijing Luhe Hospital,Capital Medical University,Beijing 101149,ChinaDepartment of Nephrology,Beijing Luhe Hospital,Capital Medical University,Beijing 101149,ChinaDepartment of Nephrology,Beijing Luhe Hospital,Capital Medical University,Beijing 101149,ChinaDepartment of Nephrology,Beijing Luhe Hospital,Capital Medical University,Beijing 101149,ChinaObjectiveTo study the correlation between serum Visfatin and cognitive impairment (CI) in maintenance hemodialysis (MHD) patients.MethodsIt was a cross-sectional study. From July 1, 2023 to January 31, 2024, baseline characteristics of MHD patients treated in the Beijing Luhe Hospital,Capital Medical University were collected. Serum level of Visfatin was evaluated using fasting blood samples. Cognitive function was assessed using the Montreal cognitive assessment scale (MoCA). According to the results of MoCA, the patients were divided into cognitive impairment (CI) group and non-CI group. Clinical characteristics were compared between groups. Multivariate logistic regression was employed for analyzing the independent influencing factors for CI. Receiver operating characteristic (ROC) curve was used to analyze the predictive value of influencing factors for CI in MHD patients.ResultsTotally 146 MHD patients were enrolled in this study and divided into non-CI group (n=46) and CI group (n=100). Compared to the non-CI group, patients in the CI group had significantly older age [66.00(57.25,71.00)years vs 45.50(40.00,56.25)years], higher proportion of diabetes (56% vs 32.6%), Visfatin level [13.35(7.68,24.68)μg/L vs 7.46(4.46,14.07)μg/L], blood sugar [(11.13 ± 5.34)mmol/L vs (9.17 ± 4.46)mmol/L], body mass index [24.29(21.24,26.21)kg/m2 vs 21.36(19.94,24.85)kg/m2], and C-reactive protein[(16.60 ± 23.37)mg/L vs (8.24 ± 10.41)mg/L] (P<0.05). Patients in the CI group had significantly lower education years[9.00(6.00,9.00)years vs 12.00(9.00,12.75)years], albumin (Alb)[40.35(37.70,42.18)g/L vs 42.15(40.28,44.58)g/L], serum creatinine [731.00(632.75,876.00)μmol/L vs 951.00(828.75,1102.50)μmol/L], blood sodium [136.5(135.0,138.0)mmol/L vs 137.5(136.0,139.0)mmol/L], and blood phosphorus [(1.68 ± 0.52)mmol/L vs(1.90 ± 0.57)mmol/L] than non-CI group (P<0.05). Multivariate logistic regression analysis showed that increasing age, high Visfatin level, low education level and Alb level were independent risk factors for CI in MHD patients. ROC curve showed that the area under the curve (AUC) of Visfatin for predicting CI in MHD patients was 0.714 (P<0.01), with the sensitivity of 71.7% and the specificity of 75.0%, which had high predictive value. When Visfatin, Alb, age and education level were combined, the AUC for predicting CI was 0.87, the sensitivity was 78.0% and the specificity was 84.8% (P < 0.01) which performed better in the predictive value than any single indicator.ConclusionFor MHD patients, high Visfatin level is an independent risk factor for CI, which may become a biological indicator for predicting CI.http://www.lcszb.com/article/doi/10.3969/j.issn.1671-2390.2025.04.007hemodialysisvisfatincognitive impairmentcross-sectional study
spellingShingle Wang Xiao-qi
Liu Cong-hui
Ma Ye-ping
Cao Qian-ying
Shao Feng
Li Zhong-xin
Correlation between serum Visfatin and cognitive impairment in maintenance hemodialysis patients
Linchuang shenzangbing zazhi
hemodialysis
visfatin
cognitive impairment
cross-sectional study
title Correlation between serum Visfatin and cognitive impairment in maintenance hemodialysis patients
title_full Correlation between serum Visfatin and cognitive impairment in maintenance hemodialysis patients
title_fullStr Correlation between serum Visfatin and cognitive impairment in maintenance hemodialysis patients
title_full_unstemmed Correlation between serum Visfatin and cognitive impairment in maintenance hemodialysis patients
title_short Correlation between serum Visfatin and cognitive impairment in maintenance hemodialysis patients
title_sort correlation between serum visfatin and cognitive impairment in maintenance hemodialysis patients
topic hemodialysis
visfatin
cognitive impairment
cross-sectional study
url http://www.lcszb.com/article/doi/10.3969/j.issn.1671-2390.2025.04.007
work_keys_str_mv AT wangxiaoqi correlationbetweenserumvisfatinandcognitiveimpairmentinmaintenancehemodialysispatients
AT liuconghui correlationbetweenserumvisfatinandcognitiveimpairmentinmaintenancehemodialysispatients
AT mayeping correlationbetweenserumvisfatinandcognitiveimpairmentinmaintenancehemodialysispatients
AT caoqianying correlationbetweenserumvisfatinandcognitiveimpairmentinmaintenancehemodialysispatients
AT shaofeng correlationbetweenserumvisfatinandcognitiveimpairmentinmaintenancehemodialysispatients
AT lizhongxin correlationbetweenserumvisfatinandcognitiveimpairmentinmaintenancehemodialysispatients